APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuromorphic Chip

Neuromorphic computing is a branch of artificial intelligence (AI) that simulates the functionality of the human neuron. This report mainly studies Neuromorphic Chip market. A neuromorphic chip is an analog data processor inspired by the biological brain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neuromorphic computing is a branch of artificial intelligence (AI) that simulates the functionality of the human neuron. This report mainly studies Neuromorphic Chip market. A neuromorphic chip is an analog data processor inspired by the biological brain.

Selected research

Market Outlook & Growth Opportunities

Global Neuromorphic Chip Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchNeuromorphic Chip Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuromorphic Chip Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Neuromorphic Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuromorphic Chip Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuromorphic Chip Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Neuromorphic computing is a branch of artificial intelligence (AI) that simulates the functionality of the human neuron. This report mainly studies Neuromorphic Chip market. A neuromorphic chip is an analog data processor inspired by the biological brain.

The industry's leading manufacturers are Intel Corporation, IBM Corporation and Eta Compute, which accounted for 18.57%, 17.43% and 17.14% of revenue in 2019.

This report provides an overview of the global Neuromorphic Chip market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Neuromorphic Chip and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuromorphic Chip revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neuromorphic Chip market.

Neuromorphic Chip Segment by Company

Intel Corporation

IBM Corporation

Eta Compute

nepes

GrAI Matter Labs

GyrFalcon

aiCTX

BrainChip Holdings

Neuromorphic Chip Segment by Type

Image Recognition

Signal Recognition

Data Mining

Neuromorphic Chip Segment by Application

Consumer Electronics

Wearable Medical Devices

Industrial Internet of Things

Others

Neuromorphic Chip Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neuromorphic Chip status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neuromorphic Chip key companies, revenue, market share, and recent developments.

3. To split the Neuromorphic Chip breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neuromorphic Chip market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neuromorphic Chip significant trends, drivers, influence factors in global and regions.

6. To analyze Neuromorphic Chip competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromorphic Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuromorphic Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromorphic Chip.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neuromorphic Chip industry.

Chapter 3: Detailed analysis of Neuromorphic Chip company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neuromorphic Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neuromorphic Chip in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neuromorphic Chip Industry Trends Table 2. Neuromorphic Chip Industry Drivers Table 3. Neuromorphic Chip Industry Opportunities and Challenges Table 4. Neuromorphic Chip Industry Restraints Table 5. Global Neuromorphic Chip Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neuromorphic Chip Revenue Share by Company (2021-2026) Table 7. Global Neuromorphic Chip Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neuromorphic Chip Key Company Manufacturing Base & Headquarters Table 9. Global Neuromorphic Chip Company, Product Type & Application Table 10. Global Neuromorphic Chip Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neuromorphic Chip by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Image Recognition Table 15. Significant Companies of Signal Recognition Table 16. Significant Companies of Data Mining Table 17. Global Neuromorphic Chip Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Neuromorphic Chip Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Neuromorphic Chip Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Neuromorphic Chip Sales Value Share by Type (2021-2026) Table 21. Global Neuromorphic Chip Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Consumer Electronics Table 23. Significant Companies of Wearable Medical Devices Table 24. Significant Companies of Industrial Internet of Things Table 25. Significant Companies of Others Table 26. Global Neuromorphic Chip Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neuromorphic Chip Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Neuromorphic Chip Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Neuromorphic Chip Sales Value Share by Application (2021-2026) Table 30. Global Neuromorphic Chip Sales Value Share by Application (2027-2032) Table 31. Global Neuromorphic Chip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Neuromorphic Chip Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Neuromorphic Chip Sales Value Share by Region (2021-2026) Table 34. Global Neuromorphic Chip Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Neuromorphic Chip Sales Value Share by Region (2027-2032) Table 36. Global Neuromorphic Chip Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Neuromorphic Chip Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Neuromorphic Chip Sales Value Market Share by Country (2021-2026) Table 39. Global Neuromorphic Chip Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Neuromorphic Chip Sales Value Market Share by Country (2027-2032) Table 41. Intel Corporation Company Information Table 42. Intel Corporation Business Overview Table 43. Intel Corporation Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Intel Corporation Neuromorphic Chip Product Portfolio Table 45. Intel Corporation Recent Development Table 46. IBM Corporation Company Information Table 47. IBM Corporation Business Overview Table 48. IBM Corporation Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IBM Corporation Neuromorphic Chip Product Portfolio Table 50. IBM Corporation Recent Development Table 51. Eta Compute Company Information Table 52. Eta Compute Business Overview Table 53. Eta Compute Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Eta Compute Neuromorphic Chip Product Portfolio Table 55. Eta Compute Recent Development Table 56. nepes Company Information Table 57. nepes Business Overview Table 58. nepes Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. nepes Neuromorphic Chip Product Portfolio Table 60. nepes Recent Development Table 61. GrAI Matter Labs Company Information Table 62. GrAI Matter Labs Business Overview Table 63. GrAI Matter Labs Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. GrAI Matter Labs Neuromorphic Chip Product Portfolio Table 65. GrAI Matter Labs Recent Development Table 66. GyrFalcon Company Information Table 67. GyrFalcon Business Overview Table 68. GyrFalcon Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GyrFalcon Neuromorphic Chip Product Portfolio Table 70. GyrFalcon Recent Development Table 71. aiCTX Company Information Table 72. aiCTX Business Overview Table 73. aiCTX Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. aiCTX Neuromorphic Chip Product Portfolio Table 75. aiCTX Recent Development Table 76. BrainChip Holdings Company Information Table 77. BrainChip Holdings Business Overview Table 78. BrainChip Holdings Neuromorphic Chip Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BrainChip Holdings Neuromorphic Chip Product Portfolio Table 80. BrainChip Holdings Recent Development Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Neuromorphic Chip Product Image Figure 2. Global Neuromorphic Chip Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuromorphic Chip Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuromorphic Chip Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Image Recognition Image Figure 8. Signal Recognition Image Figure 9. Data Mining Image Figure 10. Global Neuromorphic Chip Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Neuromorphic Chip Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Neuromorphic Chip Sales Value Share by Type (2021-2032) Figure 13. Consumer Electronics Image Figure 14. Wearable Medical Devices Image Figure 15. Industrial Internet of Things Image Figure 16. Others Image Figure 17. Global Neuromorphic Chip Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Neuromorphic Chip Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Neuromorphic Chip Sales Value Share by Application (2021-2032) Figure 20. Global Neuromorphic Chip Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Neuromorphic Chip Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Neuromorphic Chip Sales Value (2021-2032) & (US$ Million) Figure 23. North America Neuromorphic Chip Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Neuromorphic Chip Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Neuromorphic Chip Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Neuromorphic Chip Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Neuromorphic Chip Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Neuromorphic Chip Sales Value (2021-2032) & (US$ Million) Figure 29. South America Neuromorphic Chip Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Neuromorphic Chip Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Neuromorphic Chip Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Neuromorphic Chip Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Image Recognition
  • Signal Recognition
  • Data Mining
Applications
  • Consumer Electronics
  • Wearable Medical Devices
  • Industrial Internet of Things
  • Others
Companies covered
  • Intel Corporation
  • IBM Corporation
  • Eta Compute
  • nepes
  • GrAI Matter Labs
  • GyrFalcon
  • aiCTX
  • BrainChip Holdings

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neuromorphic Chip Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neuromorphic Chip Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neuromorphic Chip Market Dynamics
  1. 2.1 Neuromorphic Chip Industry Trends
  2. 2.2 Neuromorphic Chip Industry Drivers
  3. 2.3 Neuromorphic Chip Industry Opportunities and Challenges
  4. 2.4 Neuromorphic Chip Industry Restraints
3 Neuromorphic Chip Market by Company
  1. 3.1 Global Neuromorphic Chip Company Revenue Ranking in 2025
  2. 3.2 Global Neuromorphic Chip Revenue by Company (2021-2026)
  3. 3.3 Global Neuromorphic Chip Company Ranking (2024-2026)
  4. 3.4 Global Neuromorphic Chip Company Manufacturing Base and Headquarters
  5. 3.5 Global Neuromorphic Chip Company Product Type and Application
  6. 3.6 Global Neuromorphic Chip Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neuromorphic Chip Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neuromorphic Chip Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neuromorphic Chip Market by Type
  1. 4.1 Neuromorphic Chip Type Introduction
  2. 4.1.1 Image Recognition
  3. 4.1.2 Signal Recognition
  4. 4.1.3 Data Mining
  5. 4.2 Global Neuromorphic Chip Sales Value by Type
  6. 4.2.1 Global Neuromorphic Chip Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neuromorphic Chip Sales Value by Type (2021-2032)
  8. 4.2.3 Global Neuromorphic Chip Sales Value Share by Type (2021-2032)
5 Neuromorphic Chip Market by Application
  1. 5.1 Neuromorphic Chip Application Introduction
  2. 5.1.1 Consumer Electronics
  3. 5.1.2 Wearable Medical Devices
  4. 5.1.3 Industrial Internet of Things
  5. 5.1.4 Others
  6. 5.2 Global Neuromorphic Chip Sales Value by Application
  7. 5.2.1 Global Neuromorphic Chip Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neuromorphic Chip Sales Value by Application (2021-2032)
  9. 5.2.3 Global Neuromorphic Chip Sales Value Share by Application (2021-2032)
6 Neuromorphic Chip Regional Value Analysis
  1. 6.1 Global Neuromorphic Chip Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuromorphic Chip Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neuromorphic Chip Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neuromorphic Chip Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neuromorphic Chip Sales Value (2021-2032)
  7. 6.3.2 North America Neuromorphic Chip Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neuromorphic Chip Sales Value (2021-2032)
  10. 6.4.2 Europe Neuromorphic Chip Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neuromorphic Chip Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neuromorphic Chip Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neuromorphic Chip Sales Value (2021-2032)
  16. 6.6.2 South America Neuromorphic Chip Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neuromorphic Chip Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neuromorphic Chip Sales Value Share by Country, 2025 VS 2032
7 Neuromorphic Chip Country-level Value Analysis
  1. 7.1 Global Neuromorphic Chip Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neuromorphic Chip Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neuromorphic Chip Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neuromorphic Chip Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neuromorphic Chip Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neuromorphic Chip Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neuromorphic Chip Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intel Corporation
  2. 8.1.1 Intel Corporation Company Information
  3. 8.1.2 Intel Corporation Business Overview
  4. 8.1.3 Intel Corporation Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Intel Corporation Neuromorphic Chip Product Portfolio
  6. 8.1.5 Intel Corporation Recent Developments
  7. 8.2 IBM Corporation
  8. 8.2.1 IBM Corporation Company Information
  9. 8.2.2 IBM Corporation Business Overview
  10. 8.2.3 IBM Corporation Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IBM Corporation Neuromorphic Chip Product Portfolio
  12. 8.2.5 IBM Corporation Recent Developments
  13. 8.3 Eta Compute
  14. 8.3.1 Eta Compute Company Information
  15. 8.3.2 Eta Compute Business Overview
  16. 8.3.3 Eta Compute Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eta Compute Neuromorphic Chip Product Portfolio
  18. 8.3.5 Eta Compute Recent Developments
  19. 8.4 nepes
  20. 8.4.1 nepes Company Information
  21. 8.4.2 nepes Business Overview
  22. 8.4.3 nepes Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  23. 8.4.4 nepes Neuromorphic Chip Product Portfolio
  24. 8.4.5 nepes Recent Developments
  25. 8.5 GrAI Matter Labs
  26. 8.5.1 GrAI Matter Labs Company Information
  27. 8.5.2 GrAI Matter Labs Business Overview
  28. 8.5.3 GrAI Matter Labs Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GrAI Matter Labs Neuromorphic Chip Product Portfolio
  30. 8.5.5 GrAI Matter Labs Recent Developments
  31. 8.6 GyrFalcon
  32. 8.6.1 GyrFalcon Company Information
  33. 8.6.2 GyrFalcon Business Overview
  34. 8.6.3 GyrFalcon Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GyrFalcon Neuromorphic Chip Product Portfolio
  36. 8.6.5 GyrFalcon Recent Developments
  37. 8.7 aiCTX
  38. 8.7.1 aiCTX Company Information
  39. 8.7.2 aiCTX Business Overview
  40. 8.7.3 aiCTX Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  41. 8.7.4 aiCTX Neuromorphic Chip Product Portfolio
  42. 8.7.5 aiCTX Recent Developments
  43. 8.8 BrainChip Holdings
  44. 8.8.1 BrainChip Holdings Company Information
  45. 8.8.2 BrainChip Holdings Business Overview
  46. 8.8.3 BrainChip Holdings Neuromorphic Chip Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BrainChip Holdings Neuromorphic Chip Product Portfolio
  48. 8.8.5 BrainChip Holdings Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst